Currently out of the existing stock ratings of Gregg Gilbert, 151 are a BUY (74.38%), 50 are a HOLD (24.63%), 2 are a SELL (0.99%).

Gregg Gilbert

Work Performance Price Targets & Ratings Chart

Analyst Gregg Gilbert, carries an average stock price target met ratio of 58.75% that have a potential upside of 23.22% achieved within 242 days. Previously, Gregg Gilbert worked at BAML.

Gregg Gilbert’s has documented 365 price targets and ratings displayed on 28 stocks. The coverage was on Healthcare, Energy sectors.

Most recent stock forecast was given on COLL, Collegium Pharmaceutical at 25-Feb-2024.

Wall Street Analyst Gregg Gilbert

Analyst best performing recommendations are on LCI (LANNETT COMPANY).
The best stock recommendation documented was for LCI (LANNETT COMPANY) at 8/29/2019. The price target of $40 was fulfilled within 1 day with a profit of $4.48 (12.61%) receiving and performance score of 126.13.

Average potential price target upside

of $29.65 (27.07%) on LLY (ELI LILLY AND COMPANY).
of $29.61 (65.4%) on ABBV (ABBVIE).
of $26.8 (41.13%) on MRK (MERCK MPANY).

ABBV AbbVie AGN Allergan plc AKRX Akorn AMAG AMAG Pharmaceuticals ARQT Arcutis Biotherapeutics ATRS Antares Pharma BHC Bausch Health Companies ENDP Endo International PLC EOLS Evolus JAZZ Jazz Pharmaceuticals PLC LCI Lannett Company LGND Ligand Pharmaceuticals LLY Eli Lilly and Company MNK Mallinckrodt plc MRK Merck mpany MYL Viatris NVCR Novocure Ltd PFE Pfizer PRGO Perrigo Company PLC TEVA Teva Pharma Industries Ltd ADR ZTS Zoetis BMY Bristol-Myers Squibb Company COLL Collegium Pharmaceutical AMRX Amneal Pharmaceuticals, Common Stock VTRS Viatris SGNT Sagent Pharmaceuticals DHT DHT Holdings AERI Aerie Pharmaceuticals

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Geoff Meacham (CITI)